SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA completes inspection at SMS Lifesciences India’s API manufacturing facility

09 Apr 2022 Evaluate

The United States Food and Drug Administration (USFDA) has completed inspection at SMS Lifesciences India’s API manufacturing facility located at Sy. No. 180/2, Kazipally, Jinnaram Mandal, Sangareddy district, Telangana (Unit I), without any observations. The inspection commenced on April 4, 2022 and concluded on April 8, 2022.

SMS Lifesciences India is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, API and Intermediates.

Haleos Labs Share Price

1576.60 0.00 (0.00%)
14-Jul-2026 09:57 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1928.65
Dr. Reddys Labs. 1245.80
Cipla 1449.55
Zydus Lifesciences 1137.00
Lupin 2499.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: